In vivo, retatrutide produced significant reductions in body weight, adiposity, and blood glucose levels in diet-induced obese mouse models, outperforming dual GIP/GLP-1 agonists through the additional thermogenic and energy-expenditure effects mediated by glucagon receptor activation
The cornerstone of plateau management remains optimisation of diet and physical activity, as GLP-1 receptor agonists work synergistically with behavioural interventions
However, initial therapy phases may require closer monitoring, as dehydration or rapid weight loss could theoretically affect blood pressure readings
This is good for detoxification, digestion, skin health, and many other health benefits
It is not yet clear how these medications work, but studies have found that GLP-1 medications can help suppress appetite by slowing the time it takes to empty the stomach, leaving a person feeling full for longer
A caloric intake drop of anywhere from 16 to 39 percent is significant, and can lead to deficiencies in getting essential vitamins and minerals